A novel platform for addressing MS pathology and heterogeneity

Best Practice Nordic | Sep 2019 | ECTRIMS 2019 |

Galina Zheleznyakova have dentified a number of different sncRNAs where further research may pave the way for identification of informative biomarkers and possible treatment targets. In this MEdtalk she present the result from the study.